Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody designed to specifically target fibroblast growth factor receptor 1c (FGFR1c) and Klotho??. This antibody is engineered for the investigation of metabolic disorders, particularly type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). Fazpilodemab's dual targeting mechanism facilitates the study of signaling pathways that may play critical roles in the pathophysiology of these conditions.
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody designed to specifically target fibroblast growth factor receptor 1c (FGFR1c) and Klotho??. This antibody is engineered for the investigation of metabolic disorders, particularly type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). Fazpilodemab's dual targeting mechanism facilitates the study of signaling pathways that may play critical roles in the pathophysiology of these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
